Bicyclic and tricyclic heteroaromatic compounds
AssigneeNeurogen Corporation, A Corporation of the State of Delaware
InventorsJun Yuan, Pamela Albaugh, Kenneth Shaw, Alan Hutchison
Life of this patent
Estimating the term…
Abstract
Disclosed are compounds of the formula: and the pharmaceutically acceptable salts thereof, wherein W, Q, X, X1, Y and Z are as defined herein. These compounds bind with high selectivity and/or high affinity to the benzodiazepine site of GABAA receptors and are therefore useful in the treatment of central nervous system (CNS) diseases and as probes for the localization of GABAA receptors in tissue samples. Also disclosed are intermediates useful in the preparation of these compounds.
Claims30
A compound of the formula
- or a pharmaceutically acceptable salt thereof,
- wherein:
- X represents N or CR1, wherein
- R1 is hydrogen, halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, or amino(C1-C6)alkyl;
- X1 represents N, CH, or C1-C6alkyl;
- Y and Z are independently hydrogen, halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, or amino(C1-C6) alkyl;
- or
- Y and Z together form an arylene ring or a C3-C8 cycloalkylene ring, each of which is optionally substituted with up to four groups R2 independently chosen at each occurrence from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, and amino(C1-C6)alkyl;
- W is aryl or heteroaryl, each of which is optionally substituted with one or more groups RA, wherein each RA is independently
- i) halogen, hydroxy, cyano, nitro, amino, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, —SO2NH2, —SO2NH (C1-C8 alkyl), —SO2N(C1-8 alkyl) (C1-C8 alkyl), —NH(C1-C8 alkyl), —N(C1-C8 alkyl) (C1-8 alkyl), —N(C1-C8 alkyl)CO(C1-C8 alkyl), —N(C1-C8 alkyl)CO2(C1-C8 alkyl), —CONH2, —CONH(C1-C8 alkyl), —CON (C1-C8 alkyl) (C1-C8 alkyl), —CO2(C1-C8 alkyl), —S(C1-C8 alkyl), —SO(C1-C8 alkyl), or —SO2 (C1-C8 alkyl);
- ii) aryl or heteroaryl, each of which is optionally substituted with one or two groups independently selected from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, and amino (C1-C6) alkyl;
- iii) C1-C8alkyl, C2-C8alkenyl, C2-C8 alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl (C1-C3 alkyl), C3-C8cycloalkenyl, each of which is unsubstituted or substituted by one or more substitutuents independently selected from hydroxy, oxo, halogen, C1-C6alkoxy, —CONH2, —CONHC1-C6alkyl, —CON(C1-C6alkyl) (C1-C6alkyl), —COOH, and —CO2C1-C6alkyl;
- or
- iv) NR4R5, wherein R4, R5 and the nitrogen to which they are attached form a monocyclic or bicyclic ring optionally containing one or more of oxo, O, S, SO, SO2, or NR6 wherein R6 is hydrogen, C1-C6alkyl, or Ar—(C1-C6alkyl) where
- Ar is aryl or heteroaryl, each of which is optionally substituted with one or two groups independently selected from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, and amino(C1-C6)alkyl;
- and
- Q is selected Formulas III, IV and V:
- wherein:
- J is N or C1-C8 alkylene;
- and
- R9 and R10 are independently hydrogen, C1-C8 alkyl, or Ar1, wherein Ar1 is aryl or heteroaryl, each of which may be substituted with one or two of RB, where each RB independently carries the definition of RA;
- or
- R9, R10 and the atom to which they are attached form a 4- to 8-membered monocyclic or bicyclic ring optionally containing one or more double bonds or one or more of oxo, O, S, SO, SO2, or N—R8 wherein R8 is hydrogen, C1-C8 alkyl, or Ar1-(C1-C8 alkyl);
- wherein Ar1 is optionally substituted with one or two of RB, where each RB independently carries the definition of RA;
- and wherein the monocyclic or bicyclic ring is optionally substituted with C1-C6 alkyl or hydroxy(C1-C6)alkyl;
- R11 is selected from the group consisting of hydrogen, C1-C8 alkyl, C1-C8 alkanoyl, aryl(C1-C6)alkyl, and aryl(C1-C6)alkanoyl;
- and
- R12 is selected from the group consisting of hydrogen, C1-C8 alkyl, and C1-C8 alkoxy;
- or
- R11 and R12 together with the atoms to which they are attached form a 5-8 membered monocyclic ring which is optionally substituted with one or more of halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, or amino(C1-C6)alkyl;
- and
- n is 1, 2, 3, or 4;
- and
- W′
- (i) independently carries the same definition as W;
- (ii) represents —OR where R is C1-C8 alkyl or aryl(C1-C6) alkyl;
- or
- (iii) is M5 where M5 is hydroxy, C1-C8 alkyl, aryl(C1-C6)alkyl or —N(C1-C4 alkyl) (C1-C4 alkoxy).
5-10. (canceled)
12-16. (canceled)
18-19. (canceled)
21-46. (canceled)
49-53. (canceled)
55-68. (canceled)
A compound of the formula
- wherein
- X1 represents N, CH, or C1-C6alkyl;
- Y and Z are independently hydrogen, halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, or amino(C1-C6)alkyl, or
- Y and Z together form an arylene ring or a C3-C8 cycloalkylene ring, each of which is optionally substituted with up to four groups R2 independently chosen at each occurrence from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, amino(C1-C6)alkyl;
- R is C1-C6alkyl;
- RN is hydrogen, C1-C6 alkyl, or —C(O)W where
- W is aryl or heteroaryl, each of which is optionally substituted with one or more groups RA, wherein each RA is independently
- i) halogen, hydroxy, cyano, nitro, amino, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, —SO2NH2, —SO2NH(C1-C8 alkyl), —SO2N(C1-8 alkyl) (C1-C8 alkyl), —NH(C1-C8 alkyl), —N(C1-C8 alkyl) (C1-8 alkyl), —N(C1-C8 alkyl)CO(C1-C8 alkyl), —N(C1-C8 alkyl)CO2(C1-C8 alkyl), —CONH2, —CONH(C1-C8 alkyl), —CON(C1-C8 alkyl) (C1-C8 alkyl), —CO2(C1-C8 alkyl), —S(C1-C8 alkyl), —SO(C1-C8 alkyl), or —SO2 (C1-C8 alkyl);
- ii) aryl or heteroaryl, each of which is optionally substituted with one or two groups independently selected from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, and amino (C1-C6) alkyl;
- iii) C1-C8alkyl, C2-C8alkenyl, C2-C8 alkynyl, C3-C8cycloalkyl, C3-C8cycloalkyl (C1-C3 alkyl), C3-C8cycloalkenyl, each of which is unsubstituted or substituted by one or more substitutuents independently selected from hydroxy, oxo, halogen, C1-C6alkoxy, —CONH2, —CONHC1-C6alkyl, —CON(C1-C6alkyl) (C1-C6alkyl), —COOH, and —CO2C1-C6alkyl;
- iv) NR4R5, wherein R4 and R5 and the nitrogen to which they are attached form a monocyclic or bicyclic ring that may contain one or more of oxo, O, S, SO, SO2, or NR6 (wherein R6 is hydrogen, C1-C6alkyl, or Ar—(C1-C6alkyl) where
- Ar is aryl or heteroaryl each of which is optionally substituted with one or two groups independently selected from halogen, hydroxy, cyano, nitro, amino, C1-C6 alkyl, C1-C6 alkoxy, trifluoromethyl, trifluoromethoxy, mono or di(C1-C6)alkylamino, and amino(C1-C6)alkyl.
72-73. (canceled)
76-81. (canceled)
85-89. (canceled)
92-102. (canceled)
Dependencies are inferred from the claim text.